pmc logo image
Logo of medhistThe Wellcome Trust Centre of the History of Medicine (UCL)Medical History
Journal List > Med Hist > v.47(3); Jul 2003

Formats:
Med Hist. 2003 July; 47(3): 291–313.
PMCID: PMC1044630
Copyright notice
Beyond "bad news": the diagnosis, prognosis and classification of lymphomas and lymphoma patients in the age of biomedicine (1945-1995).
Peter Keating and Alberto Cambrosio
Department of History, Université du Québec à Montréal, Montréal, P.Q., Canada.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (3.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
icon of scanned page 291
291
icon of scanned page 292
292
icon of scanned page 293
293
icon of scanned page 294
294
icon of scanned page 295
295
icon of scanned page 296
296
icon of scanned page 297
297
icon of scanned page 298
298
icon of scanned page 299
299
icon of scanned page 300
300
icon of scanned page 301
301
icon of scanned page 302
302
icon of scanned page 303
303
icon of scanned page 304
304
icon of scanned page 305
305
icon of scanned page 306
306
icon of scanned page 307
307
icon of scanned page 308
308
icon of scanned page 309
309
icon of scanned page 310
310
icon of scanned page 311
311
icon of scanned page 312
312
icon of scanned page 313
313
 
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Christakis NA, Sachs GA. The role of prognosis in clinical decision making. J Gen Intern Med. 1996 Jul;11(7):422–425. [PubMed]
  • Christakis NA. The ellipsis of prognosis in modern medical thought. Soc Sci Med. 1997 Feb;44(3):301–315. [PubMed]
  • Hilden J, Habbema DF. Prognosis in medicine: an analysis of its meaning and roles. Theor Med. 1987 Oct;8(3):349–365. [PubMed]
  • Rizzi DA. Medical prognosis--some fundamentals. Theor Med. 1993 Dec;14(4):365–375. [PubMed]
  • Gospodarowicz M, Mackillop W, O'Sullivan B, Sobin L, Henson D, Hutter RV, Wittekind C. Prognostic factors in clinical decision making: the future. Cancer. 2001 Apr 15;91(8 Suppl):1688–1695. [PubMed]
  • Poston RN. A new look at the original cases of Hodgkin's disease. Cancer Treat Rev. 1999 Jun;25(3):151–155. [PubMed]
  • Lennert K. Die Beziehungen von Hodgkin- und Non-Hodgkin-Lymphomen. Arzneimittelforschung. 1987 Feb;37(2A):255–259. [PubMed]
  • Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol. 1999 Dec;10(12):1419–1432. [PubMed]
  • Harris NL. The many faces of Hodgkin's disease around the world: what have we learned from its pathology? Ann Oncol. 1998;9 Suppl 5:S45–S56. [PubMed]
  • Ménoret Marie. The genesis of the notion of stages in oncology: the French Permanent Cancer Survey (1943-1952). Soc Hist Med. 2002 Aug;15(2):291–302. [PubMed]
  • Karnofsky DA. The staging of Hodgkin's disease. Cancer Res. 1966 Jun;26(6):1090–1094. [PubMed]
  • PETERS MV, MIDDLEMISS KC. A study of Hodgkin's disease treated by irradiation. Am J Roentgenol Radium Ther Nucl Med. 1958 Jan;79(1):114–121. [PubMed]
  • Bonadonna G. Historical review of Hodgkin's disease. Br J Haematol. 2000 Sep;110(3):504–511. [PubMed]
  • LUKES RJ. RELATIONSHIP OF HISTOLOGIC FEATURES TO CLINICAL STAGES IN HODGKIN'S DISEASE. Am J Roentgenol Radium Ther Nucl Med. 1963 Nov;90:944–955. [PubMed]
  • Lukes RJ, Gompel C, Nezelof C. Le diagnostic histopathologique de la maladie de Hodgkin. Analyse préliminaire d'une étude conduite à l'aveugle sur 395 observations, par trois pathologistes de nationalité différente. Nouv Rev Fr Hematol. 1966 Jan–Feb;6(1):11–14. [PubMed]
  • Lukes RJ, Butler J, Hicks EB. Le pronostic de la maladie de Hodgkin d'après la variété histologique et le stade clinique. Rôle des réactions de l'hôte. Nouv Rev Fr Hematol. 1966 Jan–Feb;6(1):15–22. [PubMed]
  • LUKES RJ. HODGKIN'S DISEASE. PROGNOSIS AND RELATIONSHIP OF HISTOLOGIC FEATURES TO CLINICAL STAGE. JAMA. 1964 Dec 7;190:914–915. [PubMed]
  • Ultmann JE, Moran EM. Diagnostic evaluation and clinical staging in Hodgkin's disease: usefulness and problems of the Ann Arbor staging classification in primary staging and staging in relapse. Natl Cancer Inst Monogr. 1973 May;36:333–345. [PubMed]
  • Rosenberg SA, Kaplan HS. Evidence for an orderly progression in the spread of Hodgkin's disease. Cancer Res. 1966 Jun;26(6):1225–1231. [PubMed]
  • Bouroncle BA. Sternberg-Reed cells in the peripheral blood of patients with Hodgkin's disease. Blood. 1966 Apr;27(4):544–556. [PubMed]
  • Peters MV. Prophylactic treatment of adjacent areas in Hodgkin's disease. Cancer Res. 1966 Jun;26(6):1232–1243. [PubMed]
  • Kaplan HS, Rosenberg SA. Extended-field radical radiotherapy in advanced Hodgkin's disease: short-term results of 2 randomized clinical trials. Cancer Res. 1966 Jun;26(6):1268–1276. [PubMed]
  • KINMONTH JB, TAYLOR GW, HARPER RK. Lymphangiography; a technique for its clinical use in the lower limb. Br Med J. 1955 Apr 16;1(4919):940–942. [PMC free article] [PubMed]
  • Kinmonth JB, Taylor GW, Harper R Kemp. Lymphangiography. Br Med J. 1955 Apr 16;1(4919):940–942. [PMC free article] [PubMed]
  • Hellman S. Current studies in Hodgkin's disease: what laparotomy has wrought. N Engl J Med. 1974 Apr 18;290(16):894–898. [PubMed]
  • DeVita VT, Jr, Canellos GP. The lymphomas. Semin Hematol. 1999 Oct;36(4 Suppl 7):84–94. [PubMed]
  • Roth SL, Sack H, Havemann K, Willers R, Kocsis B, Schumacher V. Contiguous pattern spreading in patients with Hodgkin's disease. Radiother Oncol. 1998 Apr;47(1):7–16. [PubMed]
  • Johnson RE, O'Conor GT, Levin D. Primary management of advanced lymphosarcoma with radiotherapy. Cancer. 1970 Apr;25(4):787–791. [PubMed]
  • Banfi A, Bonadonna G, Buraggi G, Chiappa S, Di Pietro S, Felci U, Giacomelli V, Pizzetti F, Uslenghi C, Veronesi U. Proposta di classificazione e criteri terapeutici del linfosarcoma e del reticolosarcoma. Tumori. 1965 May–Jun;51(3):153–177. [PubMed]
  • Lipton A, Lee BJ. Prognosis of stage I lymphosarcoma and reticulum-cell sarcoma. N Engl J Med. 1971 Feb 4;284(5):230–233. [PubMed]
  • Johnson RE, O'Conor GT, Levin D. Primary management of advanced lymphosarcoma with radiotherapy. Cancer. 1970 Apr;25(4):787–791. [PubMed]
  • Young RC, Johnson RE, Canellos GP, Chabner BA, Brereton HD, Berard CW, DeVita VT. Advanced lymphocytic lymphoma: randomized comparisons of chemotherapy and radiotherapy, alone or in combination. Cancer Treat Rep. 1977 Sep;61(6):1153–1159. [PubMed]
  • Chaffey JT, Hellman S, Rosenthal DS, Moloney WC. Total-body irradiation in the treatment of lymphocytic lymphoma. Cancer Treat Rep. 1977 Sep;61(6):1149–1152. [PubMed]
  • Boston HC, Jr, Dahlin DC, Ivins JC, Cupps RE. Malignant lymphoma (so-called reticulum cell sarcoma) of bone. Cancer. 1974 Oct;34(4):1131–1137. [PubMed]
  • Wang CC, Fleischli DJ. Primary reticulum cell sarcoma of bone. With emphasis on radiation therapy. Cancer. 1968 Nov;22(5):994–998. [PubMed]
  • Newall J, Friedman M. Reticulum-cell sarcoma. 3. Prognosis. Radiology. 1970 Oct;97(1):99–102. [PubMed]
  • Miller TR, Nicholson JT. End results in reticulum cell sarcoma of bone treated by bacterial toxin therapy alone or combined with surgery and-or radiotherapy (47 cases) or with concurrent infection (5 cases). Cancer. 1971 Mar;27(3):524–548. [PubMed]
  • Hansen HS. Reticulum cell sarcoma treated by radiotherapy. Significance of clinical features upon the prognosis. Acta Radiol Ther Phys Biol. 1969 Dec;8(6):439–458. [PubMed]
  • Tikka U, Malmio K. Clinical and radiotherapeutic aspects of reticulum cell sarcoma. Acta Radiol Ther Phys Biol. 1969 Dec;8(6):459–470. [PubMed]
  • Goffinet DR, Warnke R, Dunnick NR, Castellino R, Glatstein E, Nelsen TS, Dorfman RF, Rosenberg SA, Kaplan HS. Clinical and surgical (laparotomy) evaluation of patients with non-Hodgkin's lymphomas. Cancer Treat Rep. 1977 Sep;61(6):981–992. [PubMed]
  • Nissen NI, Pajak T, Glidewell O, Blom H, Flaherty M, Hayes D, McIntyre R, Holland JF. Overview of four clinical studies of chemotherapy for stage III and IV non-Hodgkin's lymphomas by the Cancer and Leukemia Group B. Cancer Treat Rep. 1977 Sep;61(6):1097–1107. [PubMed]
  • Moormeier JA, Williams SF, Golomb HM. The staging of non-Hodgkin's lymphomas. Semin Oncol. 1990 Feb;17(1):43–50. [PubMed]
  • Keating Peter, Cambrosio Alberto. From screening to clinical research: the cure of leukemia and the early development of the cooperative oncology groups, 1955-1966. Bull Hist Med. 2002 Summer;76(2):299–334. [PubMed]
  • HICKS EB, RAPPAPORT H, WINTER WJ. Follicular lymphoma; a re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases. Cancer. 1956 Jul–Aug;9(4):792–821. [PubMed]
  • Lotz MJ, Chabner B, DeVita VT, Jr, Johnson RE, Berard CW. Pathological staging of 100 consecutive untreated patients with non-Hodgkin's lymphomas: extramedullary sites of disease. Cancer. 1976 Jan;37(1):266–270. [PubMed]
  • Muggia FM, Davis HL, Jr, Rozencweig M. Current cooperative clinical trials in the non-Hodgkin's lymphomas. Cancer Treat Rep. 1977 Sep;61(6):1191–1197. [PubMed]
  • Lukes RJ, Taylor CR, Parker JW, Lincoln TL, Pattengale PK, Tindle BH. A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias. Am J Pathol. 1978 Feb;90(2):461–486. [PMC free article] [PubMed]
  • Lukes RJ, Taylor CR, Parker JW, Lincoln TL, Pattengale PK, Tindle BH. A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias. Am J Pathol. 1978 Feb;90(2):461–485. [PMC free article] [PubMed]
  • Strauchen JA, Young RC, DeVita VT, Jr, Anderson T, Fantone JC, Berard CW. Clinical relevance of the histopathological subclassification of diffuse "histiocytic" lymphoma. N Engl J Med. 1978 Dec 21;299(25):1382–1387. [PubMed]
  • Nathwani BN, Dixon DO, Jones SE, Hartsock RJ, Rebuck JW, Byrne GE, Jr, Sheehan WW, Kim H, Coltman CA, Jr, Rappaport H. The clinical significance of the morphological subdivision of diffuse "histiocytic" lymphoma: a study of 162 patients treated by the Southwest Oncology Group. Blood. 1982 Nov;60(5):1068–1074. [PubMed]
  • Jones SE, Butler JJ, Byrne GE, Jr, Coltman CA, Jr, Moon TE. Histopathologic review of lymphoma cases from the Southwest Oncology Group. Cancer. 1977 Mar;39(3):1071–1076. [PubMed]
  • Ezdinli EZ, Costello W, Wasser LP, Lenhard RE, Berard CW, Hartsock R, Bennett JM, Carbone PP. Eastern Cooperative Oncology Group experience with the rappaport classification of non-Hodgkin's lymphomas. Cancer. 1979 Feb;43(2):544–550. [PubMed]
  • Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med. 1998 Nov 19;339(21):1506–1514. [PubMed]
  • Stelitano C, Baldini L, Pieresca C, Callea V, Angrilli F, Clò V, Partesotti G, Merli F, Cavanna L, Morabito F, Federico M, Brugiatelli M, Silingardi V. Validation of the international prognostic index in working formulation group A low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo Studio dei Linfomi registry. Haematologica. 2000 Feb;85(2):154–159. [PubMed]
  • Chim CS, Kwong YL, Lie AK, Lee CK, Liang R. CEOP treatment results and validity of the International Prognostic Index in Chinese patients with aggressive non-Hodgkin's lymphoma. Hematol Oncol. 1998 Sep;16(3):117–123. [PubMed]
Articles from Medical History are provided here courtesy of
The Wellcome Trust Centre for the History of Medicine at UCL

PubMed articles by these authors

Links
You are here: NCBI > Literature > PubMed Central
Write to the Help Desk